Skip to main content
Top

Journal of Cancer Survivorship

Issue 1/2007

Content (12 Articles)

Editorial

Optimizing cancer survivorship

Michael Feuerstein

Defining cancer survivorship

Michael Feuerstein

Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer

T. Wethal, J. Kjekshus, J. Røislien, T. Ueland, A. K. Andreassen, R. Wergeland, P. Aukrust, S. D. Fosså

Screening practices in cancer survivors

Deborah K. Mayer, Norma C. Terrin, Usha Menon, Gary L. Kreps, Kathy McCance, Susan K. Parsons, Kathleen H. Mooney

Exercise programming and counseling preferences in bladder cancer survivors: a population-based study

Kristina H. Karvinen, Kerry S. Courneya, Peter Venner, Scott North

Population-based survivorship research using cancer registries: a study of non-Hodgkin’s Lymphoma survivors

Neeraj K. Arora, Ann S. Hamilton, Arnold L. Potosky, Julia H. Rowland, Noreen M. Aziz, Keith M. Bellizzi, Carrie N. Klabunde, Wendy McLaughlin, Jennifer Stevens

Follow-up care for young adult survivors of cancer: lessons from pediatrics

Christine Eiser, Kate Absolom, Diana Greenfield, John Snowden, Robert Coleman, Barry Hancock, Helena Davies

Melanoma survivorship: research opportunities

Susan A. Oliveria, Jennifer L. Hay, Alan C. Geller, Maureen K. Heneghan, Mary S. McCabe, Allan C. Halpern

Preparing professional staff to care for cancer survivors

Marcia Grant, Denice Economou, Betty Ferrell, Smita Bhatia

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine